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Abstract 
Background - Acinetobacter species can exhibit widespread resistance to antimicrobial agents. 
They are recognised as important nosocomial pathogens of humans, but are becoming 
increasingly recognised in opportunistic infections of animals.  
Hypothesis/objectives - This study aimed to determine whether Acinetobacter spp. are carried on 
skin of healthy dogs and, if present, to identify the species.  
Animals - Forty dogs were sampled at veterinary practices and rescue centres. They were free 
from skin disease and receiving no systemic or topical treatments.  
Methods - Skin swab samples were collected from four sites on each dog and cultured. 
Acinetobacter spp. isolates were detected by biochemical tests and gas chromatography. The 
species was determined by sequencing the RNA polymerase β-subunit (rpoB) gene. Isolates were 
screened for OXA carbapenemase genes and class 1 integrons capable of carrying resistance 
genes, and subjected to antimicrobial susceptibility tests.  
Results - For 25% dogs sampled (10/40), Acinetobacter spp. were isolated at one or more skin 
sites. Thirteen Acinetobacter spp. isolates were recovered from 160 samples. The most frequently 
cultured was A. lwoffii (7/13), followed by A. baumannii (2/13), A. junii (1/13), A. calcoaceticus 
(1/13), A. pittii (1/13) and one novel Acinetobacter species (1/13). Class 1 integrons and blaOXA-
23-like were not detected. Isolates were susceptible to most antibiotics.  
Conclusions and clinical importance - The study confirms Acinetobacter spp. can survive on canine 
skin, where they may be potential reservoirs for infection. This highlights the importance of good 
hygiene in veterinary practice, adhering to aseptic principles in surgery, and treatment based on 
culture and susceptibility testing where possible. 
 
Introduction 
Acinetobacter spp. are Gram-negative, non-motile, aerobic bacteria that have been recovered 
from diverse environmental sources and isolated from various infections, including septicaemia,1 
and equipment such as mechanical ventilators.2 Some species, especially A. baumannii, but also 
A. pittii, A. nosocomialis and A. ursingii, amongst others, have a significant role in hospital-
acquired infections in people and often exhibit widespread resistance to antimicrobials.1,2  
Although in comparison there is limited documentation of Acinetobacter infections in animals, 
there are reports of multi-resistant Acinetobacter infections acquired in veterinary hospitals3,4 
suggesting it is emerging as a significant nosocomial pathogen in dogs.  
 
Acinetobacter spp. have been isolated from healthy companion animals at various sites such as 
the rectum and mouth,5 and one study  isolated Acinetobacter spp. from the skin of eight out of 
10 dogs, although identification was only to genus level.6 Species-level identification within the 
genus can be achieved by sequencing the RNA polymerase ß subunit gene (rpoB).7 
 
Acinetobacter baumannii is the species associated most frequently with nosocomial infections and 
outbreaks in humans;1,2 it is also recognised as a nosocomial pathogen in animals.3,4 However, 
other species have pathogenic significance.1  Acinetobacter baumannii has an intrinsic, naturally-
occurring carbapenemase gene (blaOXA-51-like), present in all isolates; PCR detection of this gene 
provides a convenient identification method for this species. BlaOXA-23-like is intrinsic to A. 
radioresistens, but is an acquired carbapenemase gene in other species of Acinetobacter, 
especially A. baumannii, in which it is consistently associated with resistance. Another useful 
marker is the class 1 integron, involved in acquisition of resistance, frequently present in 
'outbreak' strains of A. baumannii.8  A previous study found that companion animals in veterinary 
clinics shared the same clonal lineages of A. baumannii and carried the same carbapenem 
resistance determinants as those from humans.9 
 
This study was undertaken to establish whether Acinetobacter species were present on skin of 
healthy dogs and to determine the species and their distribution. This may give an indication of 
potential reservoirs for infection of susceptible animals. 
 
Materials and methods 
The sample population comprised 40 dogs, free from skin disease and not receiving any systemic 
or topical antimicrobial or corticosteroid treatment. Four establishments were visited for a diverse 
sample population and to reduce the possibility of carriage frequency being influenced by 
transmission: a companion animal hospital and rescue centre in central London (nine dogs), a 
dog rescue centre in west London (10 dogs), a veterinary practice in Hampshire (11 dogs) and a 
veterinary teaching centre in Hertfordshire (10 dogs). Sampling was carried out over a four week 
period in 2008. The procedure was approved by the teaching centre ethics committee. 
 
Swabs were taken from four skin sites on each dog: muzzle, axilla, inguinal region and the 
interdigital space between digits two and three on the left hind foot, and inoculated onto both 
nutrient agar and Leeds Acinetobacter Medium (LAM).  These media were prepared in-house. LAM 
was prepared as previously described.10 Based on a preliminary study by the first author, nutrient 
agar was the superior medium for yielding Acinetobacter species and LAM was a selective medium 
to increase the likelihood of finding Acinetobacter baumannii. 
 
Acinetobacter spp. colonies were initially selected based on morphology, a negative oxidase 
reaction and the appearance of a white colony on chromogenic agar (Brilliance UTI Agar, 
Thermo Scientific Oxoid Microbiology Products, Basingstoke, UK); see 
(http://www.oxoid.com/UK/blue/prod_detail/prod_detail.asp?pr=CM0949; accessed 
27/12/2017).  
This was followed by generic confirmation by PCR as described below. Isolates were stored on 
cryobeads at -70oC. 
 
Antibiotic susceptibility testing was by agar dilution and was carried out in 2017 on stored isolates 
and interpreted using European Committee on Antimicrobial Susceptibility Testing (EUCAST) 
recommendations and breakpoints (http://www.eucast.org/clinical_breakpoints/). 
 
Polymerase Chain Reaction (PCR) 
Amplification of the rpoB gene followed by sequencing of the amplicon was carried out as 
previously described.1 A multiplex PCR was also performed, to detect class 1 integrase, blaOXA-51-
like and blaOXA-23-like genes.1 Acinetobacter baumannii NCTC 13421 was used as a positive control. 
rpoB sequences were clustered on a BioNumerics database (Applied Maths, Sint-Martens-Latem, 
Belgium) which included the sequences of the type strains of all the currently described species. 
The gene sequence was also uploaded to the Basic Local Alignment Search Tool (BLAST) 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi), which compared and aligned the sequence to all 
publicly available Acinetobacter rpoB sequences. 
 Testing for international clones I, II and III of A. baumannii was by multiplex PCR.11 Variable 
Number Tandem Repeat (VNTR) analysis at four highly discriminatory loci  (VNTR-1, VNTR-10, 
Abaum_845 and Abaum_3468) was carried out in a single reaction using previously described 
fluorescently labelled primers and PCR products sized on a capillary sequencer (Applied 
Biosystems, Foster City, CA, USA).12 
 
Statistical analysis 
Using a statistical software package (SPSS Statistics 17.0; SPSS Inc, Chicago, IL, USA), a Chi-
square test (χ2) was performed, to test significance for the distribution of Acinetobacter species 
among the skin sites and the frequencies of isolation of the different species. Fisher’s exact tests 
were performed for those variables where there were less than five observations per cell. A P 
value of <0.05 was used as a cut off value to assess the evidence of significance of the relationship 
between the considered variables. 
 
Results 
Ten out of 40 dogs carried Acinetobacter spp. at one or more skin sites (prevalence of 25%). 
Acinetobacter-positive dogs were detected from dogs at three of four centres visited; four at the 
rescue centre, three at the veterinary practice and three at the teaching centre. Three of the 10 
dogs carried Acinetobacter spp. at two skin sites and the remainder at one site. 
 
The frequencies of isolation of Acinetobacter species from the different skin sites were similar 
(Table 1). Of the 13 isolates, four were from the muzzle, three from the axilla, three from the 
inguinal region and three from the interdigital space. 
 
Of the 160 skin swabs taken, 13 yielded Acinetobacter species. Two of the isolates possessed the 
blaOXA-51-like gene, confirming their identity as Acinetobacter baumannii. One isolate was from a 
muzzle; the other from an inguinal region of the same dog sampled at the teaching centre; neither 
possessed a class 1 integron. Both shared identical VNTR profiles (12,20,2,9), did not belong to 
international clones I, II or III (which predominate among human clinical isolates) and were 
susceptible to most antibiotics, including the carbapenems (imipenem and meropenem), 
aminoglycosides, ceftazidime, ciprofloxacin and colistin. No isolates possessed a blaOXA-23-like gene, 
the most common acquired carbapenemase gene found in Acinetobacter species in the UK. 
 
The most common Acinetobacter species isolated was A. lwoffii (seven isolates) (Table 1). The 
distribution was relatively even from skin sites. One isolate was A. junii, (muzzle), one A. pittii, 
(interdigital region) and one A. calcoaceticus (interdigital region). One isolate from an axilla, 
confirmed as belonging to the genus Acinetobacter by fatty acid analysis, did not cluster closely 
enough with any of the currently described  Acinetobacter species by rpoB sequencing, suggesting 
it represents a novel Acinetobacter species. The rpoB sequence was submitted to GenBank under 
accession number FJ157977.1 
 
In this study, the rates of isolations of Acinetobacter species from the four skin sites were not 
significantly different and statistically there was no difference between the overall isolation rates 
of each species (cut-off value p < 0.05). 
 
Discussion 
Although small, this study confirms that Acinetobacter species can be carried on healthy canine 
skin. The most significant organism in terms of its pathogenicity, A. baumannii, was isolated 
twice, from one dog. This species is rarely found on human skin or outside hospital environments 
and our findings suggest that a similar situation may exist in dogs.13 Its recovery from a patient 
at the teaching hospital could be due to transfer, directly or indirectly, from the clinical 
environment or other dogs including animals that are immunocompromised or on long-term 
antibiotic therapy. 
 
The frequencies of isolation of Acinetobacter species from the four skin sites indicate that there 
is no predilection for carriage at the sites sampled. No carriers were found at the companion 
animal hospital and rescue centre in central London. This is unlikely to be due to sampling error 
as both nutrient agar and LAM culturing was done from this clinic. These results from the only 
clinic in a city location could perhaps reflect the influence of environment on carriage of 
Acinetobacter spp. None of the isolates in this study carried blaOXA-23-like acquired carbapenemase 
gene or class 1 integrons, however a subsequent study has found blaOXA-23-like in isolates from 
dogs.9 
 
The antibiotic susceptibility of the isolates is interesting and suggests that dogs do not serve as 
a reservoir for multidrug-resistant Acinetobacter spp. but larger studies would be required to 
confirm this. Nevertheless, the fact that potentially pathogenic Acinetobacter spp. isolates can 
survive on skin highlights the importance of maintaining rigorous hygiene, disinfection and 
antisepsis, as proposed for veterinary clinics and hospitals.3  
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Table 1 Acinetobacter species cultured from each skin site from 10 dogs providing positive cultures. 
 
Species Muzzle Axilla Inguinal Interdigital Total 
A. lwoffii 2 2 2 1 7 
A. junii 1 - - - 1 
A. pittii - - - 1 1 
A. baumannii 1 - 1  2 
A. calcoaceticus - - - 1 1 
Novel species - 1 - - 1 
Total 4 3 3 3 13 
 
